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Abstract 
Merkel cell carcinoma is a rare tumor fre-
quently involving the skin with an aggressive
behavior and fatal outcome. It occurs mostly in
the caucasian race between 60-80 years of age
and it is rare in children. Herein we report our
experience  with  a  highly  aggressive  fatal
Merkel cell carcinoma in an immunocompe-
tent  17-year-old  boy.  Its  characteristics  and
treatment modalities will be also discussed.
Introduction
Merkel cell carcinoma (MCC) is an uncom-
mon neuroendocrine cutaneous tumor which
is highly aggressive.1 The median age at pres-
entation is 60-80 years and mostly affects sun-
exposed regions of head and neck. It usually
presents as a rapidly growing painless single
red  cutaneous  nodule  or  indurated  papule.2
Therefore in general MCC is a tumor of the
elderly with a lethal outcome in more than 30%
of the patients.3
Herein we report an extremely rare case of
MCC  in  a  17-year-old  boy  presented  with  a
small occipital nodule which had grown rapid-
ly  over  3  months  to  a  huge  size  of  20-
cm.Unfortunately  he  died  after  operation  in
the intensive care unit.
Case Report
A  17-year-old  boy  presented  with  a  small
nodule,  measuring  2¥2  cm  in  occipital  area
which  was  excised  by  a  local  surgeon.  The
pathologic specimen was sent to our center for
further studies. At the beginning, he was well
and in good general condition. Physical exam-
ination was unremarkable with normal blood
pressure (120/80 mmHg), pulse rate (80/min),
respiratory  rate  (12/min)  and  temperature
(37°C).  Laboratory  examination  was  also
unremarkable  i.e.  normal  complete  blood
count and biochemical indices. The received
pathology specimen consisted of an elipse of
skin and subcutaneous tissue with a subcuta-
neous  nodule  of  about  2.0  cm  in  diameter.
Microscopic findings showed a dermal based
lesion composed of strands and nests of rela-
tively  uniform,  small  and  round  cells  with
scant cytoplasm, round to oval nuclei, and pow-
dery dispersed chromatin as well as inconspic-
uous  nucleoli  (Figure  1a,b,c).  The  tumor
showed extension to the reticular dermis and
subcutis, sparing the papillary dermis, epider-
mis and adnexa. There were numerous mitot-
ic figures in the sections examined.
The immunohistochemistry results of malig-
nant  cells  showed  reactive  cytokeratin  (dot
like),  epithelial  membrane  antigen  (EMA),
Cytokeratin 20 (dot like), CD 56, neuron specif-
ic enolase (NSE), synaptophysin, neurofilament
and CD99 (Figure 2a). These cells were nega-
tive  for  leukocyte  common  antigen  (LCA),
Thyroid transcription factor-1 (TTF-1), desmin
and vimentin. Ki-67 was positive in 100% of the
tumor cells (Figure 2b). The primary diagnosis
of  cutaneous  neuroendocrine  neoplasm
(Merkel cell carcinoma) was made. Chest and
abdominal CT scan were unremarkable and no
mass was identified, so it was concluded that
the tumor was a primary neuroendocrine carci-
noma  of  skin.  Immunologic  test  including
immunoglobulin  levels  and  CD4  count  were
normal.  HIV antibody  was  also  negative. The
patient  was  referred  for  chemoradiation,  but
refused treatment and he didn’t start the thera-
py. After 3 months he came back with a huge
malodorous 20 cm occipital mass with ulcera-
tion, extensive necrosis and bleeding (Figure
3). Skull and chest CT scan and MRI were per-
formed. Underlying skull bone was involved by
tumor and also there were multiple lung metas-
tases.  Physical  examination  of  the  head  and
neck failed to show any lymphadenopathy. 
Considering the huge size and bleeding of
the tumor, a decision was made to excise the
tumor  as  completely  as  possible,  and  start
chemoradiation after surgery.
During the operation, the patient developed
severe hypotension, down to 30 mmHg (sys-
tolic pressure). However he was rescued and
the main bulk of the mass was excised. He left
the operation room to repair the site of exci-
sion by a distant free flap after a couple of
days. Unfortunately after 3 days in intensive
care unit (ICU) despite of normal blood pres-
sures, he suffered a cardiorespiratory arrest
and expired.
The received specimen in the pathology lab-
oratory  was  a  huge  irregular  necrotic  mass,
measuring 20¥17¥5 cm, covered by ulcerated
skin. Microscopy of the mass was the same as
the original biopsy and repeated immunohisto-
chemical studies showed the same results of
the initial biopsy.
Discussion
MCC is a rare, highly aggressive and usual-
ly cutaneous neuroendocrine tumor which was
first described by Toker in 1972 as a trabecular
carcinoma.4 In 1978 the same author described
the  presence  of  dense  core  granules  in  the
cytoplasm of these tumor cells and proposed
the  possible  origin  from  cutaneous  Merkel
cells.5 In 1980 the entity was called Merkel cell
carcinoma.6 The pathogenesis of MCC is not
fully understood. Recently reports have been
published about a possible viral oncogenesis of
MCC. These studies resulted in the discovery
of a new polyoma virus, the Merkel cell poly-
omavirus.7 MCC is usually a carcinoma of the
elderly with the most common location on the
sun-exposed areas of head and neck. It usually
presents as a rapidly growing red to violaceous
firm nodule.8 The most common clinical fea-
tures  of  MCC  have  been  summarized  as
AEIOU: i) A for asymptomatic/lack of tender-
ness ii) E for expanding rapidly in <3 months
iii) I for immunosuppression iv) O for older
than 50 years and 5) U for UV exposed loca-
tion. Over 90% of the patients meet 3 or more
of the AEIOU criteria.9 Our patient didn't have
2 of the criteria i.e. he was very young and
there was no evidence of any immunosuppres-
sion. MCC in the immunosuppressed patients
such as an AIDS victims or organ transplant
patient occurs at a significantly younger age.
About 50% are younger than 50 years of age.7
Although our patient didn't have any underly-
ing disease or predisposing risk factor.
Due  to  uncharacteristic  features  of  MCC,
the diagnosis in most cases is first made on
the basis of histopathologic features as was
our case.7
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MCC is a dermal-based tumor composed of
nests and cords of small round cells with round
to  oval  nuclei  and  inconspicuous  nucleoli.
These histologic subtypes are small cell, inter-
mediate  and  trabecular  variant.  However,
these  variants  are  clinically  insignificant.10
Our case was of intermediate variant which is
the most common type, composed of solid nod-
ules and diffuse sheets of basophilic cells with
round to oval relatively pale nuclei and indis-
tinct cytoplasmic borders as well as inconspic-
uous nucleoli. MCC is a very rapidly growing
tumor and the proliferative index, as well as
the amount of mitotic activity is very high.11
The histologic differential diagnoses in this
tumor are malignant melanoma, small cell car-
cinoma of lung, lymphoma and Ewing's sarco-
ma/ Primitive neuroectodermal tumor (PNET),
all of which can be excluded by immunohisto-
chemistry.10Negative HMB45, TTF-1 and CD 45
exclude tumors such as malignant melanoma,
small  cell  carcinoma  of  lung  and  lymphoma
respectively. Dot like cytoplasmic CK and CK20
are  against  the  diagnosis  of  Ewing's
sarcoma/PNET.7-9 Positive  CD99,  TdT
(Terminal  deoxynucleotidase),  paranuclear
dots by neurofilament (NF) and c-kit have also
been reported in MCC.10-13 Wide surgical exci-
sion has been reported as the only effective
treatment,  followed  by  adjuvant  chemoradia-
tion.14,15 The unique point about this patient
was  sudden  severe  and  intractable  hypoten-
sion (30 mmHg) during surgery and excision
of the tumor, which has not been reported pre-
viously,  but  seems  to  be  due  to  release  of
vasoactive  intestinal  peptide  (VIP)  from  the
tumor  cells  into  the  blood  circulation
(although we couldn’t evaluate the level).16
According to the prognosis, ten-year survival
has been revealed to be different in the tumors
less and above 2 cm. 10-year-survival rate for
tumors larger than 2 cm was reported as about
39%.17 Tumor  staging  has  been  extensively
introduced in previous reports.18 Stage of the
tumor has been reported to correlate with 10-
year survival.18MCC has a propensity to metas-
tasize to many sites, particularly lymphnodes,
lung, liver, brain and bone.19,20 To the best of
our knowledge just 2 MCCs have been reported
in the children in the English literature.21,22 As
a conclusion, our case was a remarkable one,
because of his age, absence of immunosup-
pression  and  intraoperative  hypotension,
which can be life-threatening.
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